Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

International Business Times
ibtimes.com.au > ai-forum-seoul-drug-development-impact-1875086

Seoul Forum To Ask Whether AI Can Cut A Decade Off Drug Development Amid Healthcare Revolution

6+ day, 21+ hour ago   (723+ words) ibtimes.com.au...

Endpoints News
endpoints.news > superluminal-secures-60m-for-phase-1-of-genetic-obesity-drug

Superluminal secures $60M for Phase 1 of genetic obesity drug

1+ week, 2+ day ago   (82+ words) Endpoints News Su­per­lu­mi­nal se­cures $60M for Phase 1 of ge­net­ic obe­si­ty drug A Boston biotech fol­low­ing in the foot­steps of Rhythm Phar­ma­ceu­ti­cals and oth­ers in…...

uta.edu
uta.edu > news > news-releases > 08/31/2026 > uta-uses-ai-to-advance-precision-medicine

UTA uses AI to advance precision medicine

1+ week, 5+ day ago   (229+ words) Monday, Aug 31, 2026 • Brian Lopez: Contact Junzhou Huang, a professor of computer science and engineering at The University of Texas at Arlington, is using artificial intelligence to better predict how genes and drugs might work together to treat disease. “Hopefully, we…...

Target ALS
targetals.org > news > building-the-data-foundation-for-ai-driven-als-drug-discovery

Building the Data Foundation for AI-Driven ALS Drug Discovery

2+ week, 4+ day ago   (401+ words) August 25, 2026 Manish Raisinghani Artificial intelligence is changing how researchers approach drug discovery. It can help scientists analyze large amounts of information, identify patterns that might otherwise be missed, and generate hypotheses faster than traditional approaches alone. For a disease like…...